Biolayer interferometry as an alternative to surface plasmon resonance in a biopharma regulated environment

Watch this presentation by Dr. Arnaud Delobel, R&D and Innovation Director, Strategy & Innovation, Quality Assistance S.A., titled: Biolayer interferometry as an alternative to surface plasmon resonance in a biopharma regulated environment. This talk was presented at the SelectScience^® Virtual Biopharmaceuticals Summit 2022.